4

PRIMARY DOCUMENT

Company: REVIVA PHARMACEUTICALS HOLDINGS, INC.
Filed: December 9, 2020
Period of Report: December 7, 2020
Accession Number: 0001393825-20-000141

View Document ↗ View on SEC.gov ↗